Visualization of dendritic cells’ responses in atopic dermatitis: Preventing effect of emollient

Céline Mias, Jimmy Le Digabel, Jérôme Filiol, Etienne Gontier, Eléonore Gravier, Aurélie Villaret, Thérèse Nocera, Emmanuel Questel, Ana-Beatris Rossi, Daniel Redoulès, Gwendal Josse

Experimental Dermatology

2017

Atopic dermatitis is an inflammatory condition that typically results in dry skin and itching.
A pharmacological clinical study was published in 2017 in the Experimental Dermatology journal (Impact Factor: 2.608) and showed that application of XeraCalm A.D Balm on patients suffering from atopic dermatitis prevented inflammation by blocking the early stages of the immune mechanism.

Psoriasis
Pruritus
Eczema
Seborrheic dermatitis

Development and preliminary validation of the patientreported “Chronic Itch Burden Scale”, assessing healthrelated quality of life in chronic pruritus

DUCRAY

J. Theunis, C. Nordon iD , B. Falissard, M. Orri, V. Mengeaud, L. Misery

British Journal of Dermatology

2021

View publication

Publication Summary

Visualization of dendritic cells’ responses in atopic dermatitis: Preventing effect of emollient

Our other publications on this subject

Want to read on?

Want to read on?